Valery Chatikhine, MD, PhD
Valery Chatikhine, MD, PhD, is a medical oncologist, board certified by the University of Paris — XI and Cancer Research Center of the Russian Academy of Medical Sciences, with more than 10 years of medical oncology clinical practice.
He is experienced in oncology drug development Phase I-III studies for multiple solid tumors and selected hematologic malignancies with small and large molecules (immuno-oncology), ADCs and T-cells and NK cells in solid tumors, glioblastoma and lymphoma with FDA- and EMA-relevant IND/NDAs/BLA submission and approval involvement.
In addition, Dr. Chatikhine is well published, with more than 40 publications in peer-reviewed journals (Journal of Clinical Oncology, American Journal of Clinical Oncology, European Journal of Clinical Oncology, Cancer Letters). He is an active member of the American Society of Clinical Oncology and Society for Neuro-Oncology. He joined Labcorp in April 2022.